Recent Finacing
Recent Raise
Cessatech develops and commercializes pediatric acute‑pain medicines, advancing CT001, a needle‑free nasal analgesic for acute and procedural pediatric pain, with CT002 in early development and preparing a US launch.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Cessatech.
